These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3398650)

  • 21. Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).
    Hinderliter PM; Han X; Kennedy GL; Butenhoff JL
    Toxicology; 2006 Aug; 225(2-3):195-203. PubMed ID: 16857306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How worthwhile is plasma primidone level measurement?
    Eadie MJ; Heazlewood R; Tyrer JH
    Clin Exp Neurol; 1981; 18():123-31. PubMed ID: 6926381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of nelfinavir in children: influencing factors and dose implications.
    Bergshoeff AS; Fraaij PL; van Rossum AM; Wolfs TF; Geelen SP; de Groot R; Burger DM
    Antivir Ther; 2003 Jun; 8(3):215-22. PubMed ID: 12924538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine serum levels in epileptics. Influence of age, sex, body weight and interaction with phenobarbital.
    De Michele G; Brescia Morra V; Pisanti N; Giani U; Filla A; Sinisi L; Capone D; Campanella G
    Acta Neurol (Napoli); 1985; 7(3-4):228-34. PubMed ID: 4061136
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenobarbital plasma levels in neonates.
    Pippenger CE; Rosen TS
    Clin Perinatol; 1975 Mar; 2(1):111-5. PubMed ID: 1102211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response behavior of the induction of alpha 1-acid glycoprotein by phenobarbital in the dog.
    Abramson FP
    Drug Metab Dispos; 1988; 16(4):546-50. PubMed ID: 2903021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phenobarbital and diphenylhydantoin in the plasma and phenobarbital in the cerebrospinal fluid. II. Relationship between the determination of phenobarbital in the spinal fluid and phenobarbital in the plasma].
    Isumi N
    Nihon Shonika Gakkai Zasshi; 1970 May; 74(5):552-7. PubMed ID: 5464712
    [No Abstract]   [Full Text] [Related]  

  • 28. Variability of plasma phenobarbitone concentration in Asian children in Singapore.
    Lee HS
    Ther Drug Monit; 1984; 6(2):182-8. PubMed ID: 6740737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of age and co-medication on steady-state phenobarbital serum level-dose ratios in Japanese paediatric patients.
    Yukawa E; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1992 Aug; 17(4):249-53. PubMed ID: 1429920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of concurrent administration of valproate sodium on phenobarbital plasma concentration/dosage ratio in pediatric patients.
    Suganuma T; Ishizaki T; Chiba K; Hori M
    J Pediatr; 1981 Aug; 99(2):314-7. PubMed ID: 6788924
    [No Abstract]   [Full Text] [Related]  

  • 31. Monitoring drug noncompliance in epileptic patients: assessing phenobarbital plasma levels.
    Takaki S; Kurokawa T; Aoyama T
    Ther Drug Monit; 1985; 7(1):87-91. PubMed ID: 3992626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of asphyxia on phenobarbital dosing requirements in neonates.
    Gal P; Toback J; Erkan NV; Boer HR
    Dev Pharmacol Ther; 1984; 7(3):145-52. PubMed ID: 6723489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sodium valproate on phenobarbital serum levels in children and adults.
    Fernandez de Gatta MR; Alonso Gonzalez AC; Garcia Sanchez MJ; Dominguez-Gil Hurle A; Santos Borbujo J; Monzon Corral L
    Ther Drug Monit; 1986; 8(4):416-20. PubMed ID: 3103264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum phenobarbital concentration predictions by a personal computer software system.
    Gingery JW; Embil AS; Robinson JD; Jernigan JA
    Drug Intell Clin Pharm; 1987 Nov; 21(11):895-900. PubMed ID: 3678064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic drug monitoring of phenobarbital].
    Gomita Y; Furuno K; Araki Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1137-9. PubMed ID: 2355513
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monitoring of phenobarbital use during the neonatal period by means of urinalysis].
    Fabris C; Licata D; Tappi E; Cavo L; Voglino GF
    Pediatr Med Chir; 1988; 10(5):493-4. PubMed ID: 3241753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we safely administer the recommended dose of phenobarbital in very low birth weight infants?
    Oztekin O; Kalay S; Tezel G; Akcakus M; Oygur N
    Childs Nerv Syst; 2013 Aug; 29(8):1353-7. PubMed ID: 23559395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of age on concurrent administration of phenobarbital and valproic acid.
    Curatolo P
    J Pediatr; 1982 May; 100(5):841-2. PubMed ID: 6802950
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between serum levels and fast EEG activities in rats by a single administration of phenobarbital.
    Sato H
    Electroencephalogr Clin Neurophysiol; 1980 Dec; 50(5-6):509-14. PubMed ID: 6160994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once daily doses of phenobarbital in children.
    Walson PD; Mimaki T; Curless R; Mayersohn M; Perrier D
    J Pediatr; 1980 Aug; 97(2):303-5. PubMed ID: 7400905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.